Milan Radoje Uskokovic

Milan Radoje Uskokovic's AcademicInfluence.com Rankings

Medical

#2983

World Rank

#3432

Historical Rank

Pharmacology

#342

World Rank

#393

Historical Rank

medical Degrees

Download Badge

Medical

Milan Radoje Uskokovic's Degrees

PhD Pharmacology University of Belgrade
Masters Pharmacology University of Belgrade
Bachelors Pharmacy University of Belgrade

Why Is Milan Radoje Uskokovic Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Milan Radoje Uskokovic's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure (2004) (592)
A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice (2002) (440)
Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands (2004) (211)
20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. (1995) (201)
A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. (2002) (199)
Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. (1997) (194)
Total synthesis of 1233A (1993) (174)
Direct α-iodination of cycloalkenones (1992) (174)
1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. (1994) (166)
1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice. (1990) (166)
Stereocontrolled total synthesis of 1.alpha.,25-dihydroxycholecalciferol and 1.alpha.,25-dihydroxyergocalciferol (1986) (162)
Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. (2004) (152)
Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3. (1994) (144)
Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization. (1989) (140)
The Nuclear Magnetic Resonance Spectra of the Angular Proton in Benzo[a]- and Indolo[a]quinolizidines (1964) (127)
Synergistic growth inhibition of prostate cancer cells by 1α,25 Dihydroxyvitamin D3 and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A† (2001) (127)
A radioimmunoassay for 1,25-dihydroxycholecalciferol. (1978) (117)
Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases (2003) (105)
1 alpha, 25-Dihydroxyvitamin D3 inhibits phorbol ester-dependent chemical carcinogenesis in mouse skin. (1983) (102)
Diastereomeric solute-solute interactions of enantiomers in achiral solvents. Nonequivalence of the nuclear magnetic resonance spectra of racemic and optically active dihydroquinine (1969) (101)
Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. (1991) (97)
A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia. (1996) (95)
Structure-Function Studies on Analogues of 1α,25-Dihydroxyvitamin D3: Differential Effects on Leukemic Cell Growth, Differentiation, and Intestinal Calcium Absorption (1990) (89)
Altered Nuclear Receptor Corepressor Expression Attenuates Vitamin D Receptor Signaling in Breast Cancer Cells (2006) (89)
5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells. (1999) (88)
Asymmetric synthesis of loganin. Stereospecific formation of (1R,2R)- and (1S,2S)-2-methyl-3-cyclopenten-1-ol and (2R)- and (2S)-2-methylcyclopentanone (1973) (86)
Stereoselective total synthesis of 1.alpha.,25-dihydroxycholecalciferol (1982) (86)
A Novel Gemini Vitamin D Analog Represses the Expression of a Stem Cell Marker CD44 in Breast Cancer (2011) (86)
Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. (2001) (81)
Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels. (1995) (81)
Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia (2006) (79)
Analogs of 1α,25-dihydroxyvitamin D3 as novel inhibitors of renin biosynthesis (2005) (78)
Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol) (2007) (78)
Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions. (2000) (77)
Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. (1993) (77)
Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer. (2006) (75)
Expression of Retinoic Acid Receptor-β Sensitizes Prostate Cancer Cells to Growth Inhibition Mediated by Combinations of Retinoids and a 19-nor Hexafluoride Vitamin D3 Analog. (1998) (75)
Vitamin D3 metabolites. I. Synthesis of 25-hydroxycholesterol. (1974) (73)
Total synthesis of acosamine and daunosamine utilizing a diastereoselective intramolecular [3+2] cycloaddition (1985) (72)
A chiral synthesis of L-acosamine and L-daunosamine via an enantioselective intramolecular[3 + 2]cycloaddition (1981) (71)
Asymmetric synthesis of prostaglandin intermediates. (1973) (70)
Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo (2004) (68)
Triply convergent synthesis of 1.alpha.,25-dihydroxy-24(R)-fluorocholecalciferol (1988) (67)
Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists. (2000) (66)
1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia. (1994) (66)
1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse. (2002) (65)
Highly potent transcriptional activation by 16-ene derivatives of 1,25-dihydroxyvitamin D3. Lack of modulation by 9-cis-retinoic acid of response to 1,25-dihydroxyvitamin D3 or its derivatives. (1994) (62)
19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines. (1998) (58)
Synergistic Antileukemic Activity of Carnosic Acid-Rich Rosemary Extract and the 19-nor Gemini Vitamin D Analogue in a Mouse Model of Systemic Acute Myeloid Leukemia (2008) (57)
19-nor-hexafluoride analogue of vitamin D3: a novel class of potent inhibitors of proliferation of human breast cell lines. (1997) (57)
Gemini Vitamin D Analogues Inhibit Estrogen Receptor–Positive and Estrogen Receptor–Negative Mammary Tumorigenesis without Hypercalcemic Toxicity (2008) (56)
Selective inhibition of cyclooxygenase‐2 (COX‐2) by 1α,25‐dihydroxy‐16‐ene‐23‐yne‐vitamin D3, a less calcemic vitamin D analog (2008) (56)
19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells. (1998) (56)
Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis. (2011) (56)
Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion. (1997) (56)
Asymmetric synthesis of allo-heteroyohimbine alkaloids (1979) (55)
19-nor-10-ketovitamin D derivatives: unique metabolites of vitamin D3, vitamin D2, and 25-hydroxyvitamin D3. (1983) (54)
Antiproliferative signalling by 1,25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation. (2003) (52)
Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3. (1995) (52)
1,25-dihydroxyvitamin D3 synthetic analogs inhibit spontaneous metastases in a 1,2-dimethylhydrazine-induced colon carcinogenesis model. (2000) (52)
Targeting CD44-STAT3 Signaling by Gemini Vitamin D Analog Leads to Inhibition of Invasion in Basal-Like Breast Cancer (2013) (51)
The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells (2006) (51)
Isolation and identification of 1α‐hydroxy‐3‐epi‐vitamin D3, a potent suppressor of parathyroid hormone secretion (2005) (51)
Olefinic nitrone and nitrile oxide [3 + 2] cycloadditions. A short stereospecific synthesis of biotin from cycloheptene (1980) (50)
Stereospecific total synthesis of d-biotin from L(+)-cysteine. (1975) (50)
Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer (2015) (50)
Total synthesis of quinine and quinidine. I. (1970) (49)
Synthesis and structure proof of a vitamin D3 metabolite, 25(s),26-dihydroxycholecalciferol (1981) (49)
Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed. (1999) (49)
An evaluation of 1,25-dihydroxyvitamin D3 analogues on the proliferation and differentiation of cultured human keratinocytes, calcium metabolism and the differentiation of human HL-60 cells (1993) (49)
Highly active analogs of 1α,25-dihydroxyvitamin D3 that resist metabolism through C-24 oxidation and C-3 epimerization pathways (2001) (49)
1 Alpha-25,26-trihydroxyvitamin D3: an in vivo and in vitro metabolite of vitamin D3. (1981) (46)
Targeting 1α,25-dihydroxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors (2004) (46)
Use of intramolecular [3 + 2] cycloaddition reactions in the synthesis of natural products. A stereospecific synthesis of (.+-.)-biotin from cycloheptene (1978) (45)
Novel synthesis of racemic ajmalicine, 19-epiajmalicine, tetrahydroalstonine and akuammigine (1971) (44)
Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines (1997) (44)
Vitamin D3 analogs stimulate hair growth in nude mice. (2002) (44)
Cellular and molecular events associated with the bone-protecting activity of the noncalcemic vitamin D analog Ro-26-9228 in osteopenic rats. (2002) (44)
Control of stereoselectivity in samarium metal induced cyclopropanations. Synthesis of 1,25-dihydroxycholecalciferol (1991) (42)
Differential activities of 1α,25-dihydroxy-16-ene-vitamin D3 analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis (2001) (42)
Vitamin D3 metabolites. II. Further syntheses of 25-hydroxycholesterol. (1974) (42)
Antiproliferative effects in vitro and in vivo of 1,25-dihydroxyvitamin D3 and a vitamin D3 analog in a squamous cell carcinoma model system (1995) (41)
HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44+/CD24−/low tumor-initiating subpopulation in basal-like breast cancer (2015) (41)
Evidence for tissue‐ and cell‐type selective activation of the vitamin D receptor by Ro‐26‐9228, a noncalcemic analog of vitamin D3 (2003) (41)
Total synthesis of Cinchona alkaloids. 2. Stereoselective total syntheses of quinine and quinidine (1978) (41)
The photoproduction of 1 alpha,25-dihydroxyvitamin D3 in skin: an approach to the therapy of vitamin-D-resistant syndromes. (1980) (40)
The 16-Ene Vitamin D Analogs (1997) (40)
Bone resorption, renal function and mineral status in cows treated with 1,25-dihydroxycholecalciferol and its 24-fluoro analogues. (1986) (39)
Gemini vitamin D analog suppresses ErbB2-positive mammary tumor growth via inhibition of ErbB2/AKT/ERK signaling (2010) (39)
Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft. (1998) (39)
(23S)-1,23,25-Trihydroxyvitamin D3: its biologic activity and role in 1 alpha,25-dihydroxyvitamin D3 26,23-lactone biosynthesis. (1984) (38)
Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway (2006) (36)
Synthesis of d-biotin from L-cystine via intramolecular [3+2]cycloaddition (1982) (36)
Chemical conversion of vitamin D3 to its 1,35-dihydroxy metabolite (1991) (36)
The antiproliferative effect of vitamin D analogs on MCF-7 human breast cancer cells. (1995) (35)
Synthesis of Tetrahydrolipstatin. (1991) (34)
Effects of long-term administration of vitamin D3 analogs to mice. (2000) (34)
Analogs of 1alpha,25-dihydroxyvitamin D(3) as novel inhibitors of renin biosynthesis. (2005) (34)
A stereoselective synthesis of the 24(R),25-dihydroxycholesterol side chain. (1976) (34)
ASYMMETRIC SYNTHESIS OF LOGANIN, STEREOSPECIFIC FORMATION OF (1R,2R)- AND (1S,2S)-2-METHYL-3-CYCLOPENTEN-1-OL AND (2R)- AND (2S)-2-METHYL-CYCLOPENTANONE (1973) (34)
A 1 , 25-Dihydroxyvitamin D 3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice (2002) (33)
Total synthesis of Cinchona alkaloids. 1. Synthesis of meroquinene (1978) (33)
6-trans-16-ene-Vitamin D 3 : A New Class of Potent Inhibitors of Proliferation of Prostate , Breast , and Myeloid Leukemic Cells 1 (1999) (33)
Syntheses in the isoquinoline series. Synthesis of 2,3-dihydro-4(1H)-isoquinolones (1968) (33)
Stereoselective Introduction of Steroid Side Chains at C (17) and C (20) (1981) (32)
Ability of potent vitamin D3 analogs to inhibit growth of prostate cancer cells in vivo. (2003) (32)
23S,25-dihydroxyvitamin D3 as a circulating metabolite of vitamin D3. Its role in 25-hydroxyvitamin D3-26,23-lactone biosynthesis. (1982) (32)
Novel Gemini vitamin D3 analogs have potent antitumor activity (2008) (32)
Reinvestigation of the Classical Synthesis of Cinchona Alkaloids. II. The synthesis of quinine and its naturally occurring diastereomers from quinotoxine (1973) (32)
Stimulatory effect of 1 alpha, 25-dihydroxyvitamin D3 on the formation of skin tumors in mice treated chronically with 7,12-dimethylbenz[a]anthracene. (1985) (32)
A stereospcific synthesis of biotin via thiophene intermediates1a. (1977) (31)
Functional block for 1 alpha,25-dihydroxyvitamin D3-mediated gene regulation in human B lymphocytes. (1994) (31)
Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor. (2003) (31)
Translational study of vitamin D differentiation therapy of myeloid leukemia: effects of the combination with a p38 MAPK inhibitor and an antioxidant (2005) (31)
Synergistic induction of HL60 cell differentiation by ketoconazole and 1-desoxy analogues of vitamin D3. (1997) (31)
1α,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1α,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells (1996) (30)
Remote diastereoselection in the asymmetric total synthesis of mevinolin (1989) (30)
24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation. (2001) (30)
Convergent Synthesis of Vitamin D3 Metabolites. Control of the Stereoselectivity in Samarium-Induced Cyclopropanations of Cyclopentenes (1996) (30)
Combination therapy of a vitamin D3 analog and all-trans-retinoic acid: effect on human breast cancer in nude mice. (1999) (30)
Synthesis and anti-inflammatory properties of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-24-oxo-vitamin D3, a hypocalcemic, stable metabolite of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-vitamin D3. (2009) (29)
Loss of Deoxycytidine Kinase Expression and Tetraploidization of HL60 Cells Following Long-Term Culture in 1,25-Dihydroxyvitamin D3 (1996) (29)
Vitamin D3 Metabolites III. Synthesis and X‐ray analysis of 1α, 25‐dihydroxycholesterol (1974) (29)
Total synthesis of pseudomonic acid C (1988) (29)
Calcitriol derivatives with two different side chains at C-20. V. Potent inhibitors of mammary carcinogenesis and inducers of leukemia differentiation. (2009) (29)
Biological effects of 1alpha-hydroxy- and 1beta-(hydroxymethyl)-vitamin D compounds relevant for potential colorectal cancer therapy. (1999) (28)
Interaction of retinoic acid and vitamin D3 analogs on HL-60 myeloid leukemic cells. (1993) (28)
Effect of cellular environment on the selective activation of the vitamin D receptor by 1alpha,25-dihydroxyvitamin D3 and its analog 1alpha-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin D3 (Ro-26-9228). (2004) (28)
TOTAL SYNTHESIS OF CINCHONA ALKALOIDS. 4. SYNTHESES VIA QUINUCLIDINE PRECURSORS (1978) (28)
Effect of 1,25,28‐trihydroxyvitamin D2 and 1,24,25‐trihydroxyvitamin D3 on intestinal calbindin‐D9K mRNA and protein: Is there a correlation with intestinal calcium transport? (1993) (27)
Structure-function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097. (2011) (26)
C-20 STEREOSPECIFIC INTRODUCTION OF A STEROID SIDE CHAIN (1981) (26)
Letter: A'stereospecific total synthesis of d-biotin from L-(+)-cysteine. (1975) (26)
Formal Desymmetrization of the Diastereotopic Chains in Gemini Calcitriol Derivatives with Two Different Side Chains at C-20 (2004) (25)
Expression of retinoic acid receptor-beta sensitizes prostate cancer cells to growth inhibition mediated by combinations of retinoids and a 19-nor hexafluoride vitamin D3 analog. (1998) (25)
Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. (1990) (25)
Silibinin can induce differentiation as well as enhance vitamin D3‐induced differentiation of human AML cells ex vivo and regulates the levels of differentiation‐related transcription factors (2009) (25)
Asymmetric synthesis of a key 1α,25-dihydroxy-vitamin D3 ring a synthon (1992) (24)
1α,25-Dihydroxy-16-ene-23-yne-vitamin D3 and 1α,25-Dihydroxy-16-ene-23-yne-20-epi-vitaminD3: Analogs of 1α,25-Dihydroxyvitamin D3 That Resist Metabolism through the C-24 Oxidation Pathway Are Metabolized through the C-3 Epimerization Pathway (2000) (24)
1 alpha, 25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531) modulation of insulin-like growth factor-binding protein-3 and induction of differentiation and growth arrest in a human osteosarcoma cell line. (1996) (24)
Effects of 1α,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-β estradiol (1996) (23)
An Efficient Stereoselective Synthesis of (±)‐Sweroside and (±)‐secologanin aglucone O‐methyl ethers. Preliminary communication (1978) (23)
ASYMMETRIC SYNTHESIS OF PROSTAGLANDIN INTERMEDIATES (1973) (22)
Novel Gemini analogs of 1α,25-dihydroxyvitamin D3 with enhanced transcriptional activity (2004) (22)
A new approach to the total synthesis of pseudomonic acid C (1987) (22)
Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships. (1995) (22)
Syntheses in the isoquinoline series. Synthesis and chemical transformation of 2,3-dihydro-4(1H)-isoquinolones (1968) (22)
cis-diamminedichloroplatinum(II) cross-linking of the human myeloid cell nuclear differentiation antigen to DNA in HL-60 cells following 1,25-dihydroxy vitamin D3-induced monocyte differentiation. (1990) (22)
Epimeric 3-vinyl-4-piperdineacetic acids, synthetic precursors of cinchoma and indole alkaloids (1971) (22)
Synthesis of daunosamine (1983) (22)
1,25‐dihydroxyvitamin D3 stimulates avian and mammalian cartilage growth in vitro (1988) (21)
Metabolism of 1,25(OH)216-ene D3 in kidney: influence of structural modification of D-ring on side chain metabolism (1993) (21)
Synthesis of racemic Prelog-Djerassi lactone via a regio- and diastereoselective ene reaction (1982) (21)
A Novel Vitamin D Derivative Activates Bone Morphogenetic Protein Signaling in MCF10 Breast Epithelial Cells (2006) (21)
Synthesis of cinchona alkaloids via quinuclidine precursors (1971) (21)
Stereospecific synthesis of the lythgoe's ring a aldehyde for the preparation of 1α-hdroxylated tachysterols and calciferols (1987) (21)
3H-1,4-Benzodiazepine-2,5(1H,4H)-dione and Related Compounds (1962) (20)
Oral Administration of a Gemini Vitamin D Analog, a Synthetic Triterpenoid and the Combination Prevents Mammary Tumorigenesis Driven by ErbB2 Overexpression (2013) (20)
A stereospecific synthesis of biotin from an aromatic precursor. (1976) (20)
Calcitriol derivatives with two different side chains at C-20 III. An epimeric pair of the gemini family with unprecedented antiproliferative effects on tumor cells and renin mRNA expression inhibition (2007) (20)
Diastereotopic and deuterium effects in gemini. (2013) (20)
Total synthesis of 1.alpha.-fluoro-25-hydroxycholecalciferol and -ergocalciferol (1990) (19)
Synergistic inhibition of prostate cancer cell lines by a 19- nor hexafluoride vitamin D3 analogue and anti-activator protein 1 retinoid (1999) (19)
Metabolism of 1α,25-dihydroxyvitamin D3 in human promyelocytic leukemia (HL-60) cells: In vitro biological activities of the natural metabolites of 1α,25-dihydroxyvitamin D3 produced in HL-60 cells (2001) (19)
A new synthesis of 7-dehydrocholesterols (1981) (18)
20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. (1999) (18)
Plasma concentrations of 1,25-dihydroxyvitamin D, 1,24R,25-trihydroxyvitamin D3, and 2,25,26-trihydroxyvitamin D3 after their administration to dairy cows. (1983) (18)
and Inducers of Differentiation of Human Breast Cancer Cell Lines (1995) (18)
Total synthesis of 1.alpha.,25(R)-dihydroxy vitamin D3 26, 23(S)-lactone (calcitriol lactone), a natural metabolite of vitamin D3 (1983) (17)
Asymmetric synthesis of daunosamine (1983) (17)
Total synthesis of Cinchona alkaloids. 3. Syntheses of quinuclidine intermediates (1978) (17)
Signaling of monocytic differentiation by a non‐hypercalcemic analog of vitamin D3, 1,25(OH)2‐5,6 trans‐16‐ene‐vitamin D3, involves nuclear vitamin D receptor (nVDR) and non‐nVDR–mediated pathways (2002) (17)
A Nonphotolytic Synthesis of 10α- and 9β,10α-Progesterone (1966) (16)
(25 S)-1α, 25, 26-Trihydroxycholecalciferol, a New Vitamin D3 Metabolite: Synthesis and Absolute Stereochemistry at C(25) (1981) (16)
23-carboxy-24,25,26,27-tetranorvitamin D3 (calcioic acid) and 24-carboxy-25,26,27-trinorvitamin D3 (cholacalcioic acid): end products of 25-hydroxyvitamin D3 metabolism in rat kidney through C-24 oxidation pathway. (2006) (16)
Physiological Significance of C-28 Hydroxylation in the Metabolism of 1α,25-Dihydroxyvitamin D2 (1999) (15)
Reinvestigation of the Classical Synthesis of Cinchona Alkaloids. I. A new synthesis of homomeroquinene and quinotoxine (1973) (15)
The Conversion of 4,1-Benzoxazepine-2,5(1H,3H)-diones into 2-(α-Hydroxyalkyl)-4-quinazolinones (1964) (15)
Remote diastereoselection in the asymmetric synthesis of pravastatin (1992) (15)
The structure and absolute configuration of arteannuin B. (1974) (15)
D-Homosteroids. IV.1 17β,17aβ-Dimethyl-17α-17aα-dihydroxy- and 17,17-Dimethyl-17a-keto-D-homosteroids2 (1960) (14)
Induction of tissue plasminogen activator secretion from rat heart microvascular cells by fM 1,25(OH)(2)D(3). (2000) (14)
Inhibition of the Transition of Ductal Carcinoma In Situ to Invasive Ductal Carcinoma by a Gemini Vitamin D Analog (2014) (14)
Stereocontrolled Total Synthesis of 1α,25‐Dihydroxycholecalciferol (Ia) and 1α,25‐Dihydroxyergocalciferol (Ib). (1987) (13)
Activation of bone morphogenetic protein signaling by a Gemini vitamin D3 analogue is mediated by Ras/protein kinase C alpha. (2007) (13)
Synthesis of d-biotin from cysteine (1987) (13)
Calcitriol derivatives with two different side-chains at C-20. Part 4: further chain modifications that alter VDR-dependent monocytic differentiation potency in human leukemia cells. (2007) (13)
Vitamin D analog 25‐(OH)‐16,23E‐diene‐26,27‐hexafluoro‐vitamin D3 induces differentiation of HL60 cells with minimal effects on cellular calcium homeostasis (1996) (13)
A STEREOSELECTIVE SYNTHESIS OF THE 24(R),25-DIHYDROXYCHOLESTEROL SIDE CHAIN (1976) (13)
C-20 cyclopropyl vitamin D3 analogs. (2006) (12)
Calcitriol derivatives with two different side chains at C-20 24-Hydroxy derivatives as metabolic products and molecular probes for VDR exploration (2004) (12)
A new insight into the role of rat cytochrome P450 24A1 in metabolism of selective analogs of 1α,25-dihydroxyvitamin D₃. (2011) (12)
Use of Fourier transform 1H NMR in the identification of vitamin D2 metabolites. (1987) (12)
Binding properties of 23S,25-dihydroxyvitamin D3: an in vivo metabolite of vitamin D3. (1982) (12)
Stereocontrolled synthesis of 19-epiajmalicine from loganin aglucone (1988) (11)
Total synthesis of pentaline (1968) (11)
Determination of the absolute configuration of 4-phenyl-1,2,3,4- tetrahydroisoquinolines utilizing ord and cd spectroscopy (1970) (11)
The biological activities of 1alpha,25-dihydroxyvitamin D3 and its synthetic analog 1alpha,25-dihydroxy-16-ene-vitamin D3 in normal human osteoblastic cells and human osteosarcoma SaOS-2 cells are modulated by 17-beta estradiol and dependent on stage of differentiation. (2001) (11)
Synthesis of 9-epi-quinine and 9-epi-quinidine. (1972) (11)
Antimalarial activity of natural, racemic and unnatural dihydroquinine, dihydroquinidine and their various racemic analogs in mice infected withPlasmodium berghei (1971) (11)
Asymmetric synthesis of a key ring A synthon for 1α-hydroxy-19-nor vitamin D (1998) (10)
Metabolites and analogs of 1α,25-dihydroxyvitamin D3: evaluation of actions in bone (2001) (10)
Lead Tetraacetate Fragmentation of Loganin Aglucone O-Metheyl Ether and its Stereoisomers (1971) (10)
Syntheses in the isoquinoline series. Selective demethylation of 6,7- and 7,8-dimethoxy-2,3-dihydro-4(1H)-isoquinolones (1968) (10)
A low-calcemic vitamin D analog (Ro 25-4020) inhibits the growth of LNCaP human prostate cancer cells with increased potency by producing an active 24-oxo metabolite (Ro 29-9970). (2003) (10)
Calcitriol derivatives with two different side chains at C-20. II. Diastereoselective syntheses of the metabolically produced 24(R)-hydroxygemini. (2004) (10)
The 16-Ene Vitamin D Analogues (1997) (10)
The Synthesis of 4,1-Benzothiazepines and 5,1-Benzothiazocines (1965) (10)
A radioimmunoassay for 1,25-dihydroxycholecalciferol. (1978) (10)
Total synthesis of racemic ajmalicine and 19‐epi‐ajmalicine (1981) (10)
Total synthesis of 25-hydroxy-16,23E-diene vitamin D3 and 1 alpha,25-dihydroxy-16,23E-diene vitamin D3: separation of genomic and nongenomic vitamin D activities. (1998) (10)
The Stereoselectivity of Ketone Reduction with Sporotrichum Exile. Resolution of cis- and trans-2-benzoyloctahydro-6(2H)-isoquinolones (1973) (9)
A Preparation of 3β-Hydroxypregn-5-en-20-one-4-C14 (1958) (9)
Characterization of five 19-nor-analogs of 1α,25(OH)2-Vitamin D3 with 20-cyclopropyl-modified side-chains: implications for ligand binding and calcemic properties (2004) (9)
Compactin from hajós (−)-enedione (1990) (9)
TOTAL SYNTHESIS OF 1α,25(R)-DIHYDROXY VITAMIN D3 26, 23(S)-LACTONE (CALCITRIOL LACTONE), A NATURAL METABOLITE OF VITAMIN D3 (1984) (9)
1-Phenyl-2-(α-hydroxyalkyl)-4(1H)-quinazolinones (1965) (8)
Differential activities of 1alpha,25-dihydroxy-16-ene-vitamin D(3) analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis. (2001) (8)
4-Aza-17α-methyl-17β-hydroxyandrost-5-en-3-one and Methyltestosterone-4-C14,12 (1961) (8)
Total synthesis of quinine and quinidine. II. (1970) (8)
Stereoselective Introduction of Steroid Side Chains. Synthesis of Chenodeoxycholic Acid (1984) (8)
Increased sensitivity to a vitamin D3 analog in HL-60 myeloid leukemic cells resistant to all-trans retinoic acid. (1994) (8)
Cinchona Alkaloids. Total Synthesis of Cinchonamine. Preliminary Communication (1976) (8)
Effects of 1,25(OH)2D3 and vitamin D analogs on developmental control of cell growth and tissue-specific gene expression during osteoblast differentiation (1993) (8)
Isolation and identification of 4,25-dihydroxyvitamin D2: a novel A-ring hydroxylated metabolite of vitamin D2 (1999) (8)
Notes - Radioactive Estrogens (1957) (8)
An approach to the synthesis of the hexahydronaphthalene unit of pravastatin (1990) (8)
THE 16-ENE ANALOGS OF 1,25-DIHYDROXYCHOLECALCIFEROL. SYNTHESIS AND BIOLOGICAL ACTIVITY (1991) (7)
Des-A-pregnanes. Degradation of 11-alpha-hydroxyprogesterone. (1968) (7)
Synergistic Induction of HL 60 Cell Differentiation by Ketoconazole and 1-Desoxy Analogues of Vitamin D 3 (1997) (7)
A total synthesis of biotin based on derivatives of 2,5-dihydrothiophene. (1977) (7)
Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-beta estradiol. (1996) (7)
Effects of vitamin D derivatives on soft tissue calcification in neonatal and calcium mobilization in adult rats (2004) (7)
1,25-(OH)2-16ene-23yne-D3 Reduces Secondary Hyperparathyroidism in Uremic Rats with Little Calcemic Effect (2004) (7)
Concise Synthesis of Dimethyl (2-Oxopropyl)phosphonate and Homologation of Aldehydes to Alkynes in a Tandem Process (2008) (7)
Triply Convergent Synthesis of 1α,25-Dihydroxy-24(R)-fluorocholecalciferol (I). (1988) (7)
Reduction of 7α-Bromosteroids with Tritium1 (1960) (7)
Total Synthesis of Dihydrocinchonamine (1972) (7)
Novel Gemini analogs of 1alpha,25-dihydroxyvitamin D(3) with enhanced transcriptional activity. (2004) (6)
Loss of deoxcytidine kinase expression and tetraploidization of HL60 cells following long-term culture in 1,25-dihydroxyvitamin D3. (1996) (6)
Double bond in the side chain of 1α,25-dihydroxy-22-ene-vitamin D3 is reduced during its metabolism: studies in chronic myeloid leukemia (RWLeu-4) cells and rat kidney (2001) (6)
Isolation and identification of 1α-hydroxy-24-oxovitamin D3 and 1α,23-dihydroxy-24-oxovitamin D3: Metabolites of 1α,24(R)-dihydroxyvitamin D3 produced in rat kidney (1999) (6)
1alpha,25-dihydroxy-3-epi-vitamin D3: in vivo metabolite of 1alpha,25-dihydroxyvitamin D3 in rats. (1999) (6)
Inhibition of Type 1 Diabetes Development by Vitamin D Receptor Agonists (2005) (6)
Structures of two diastereoisomeric sulfoxides. 3,5-Dihydro-3-methyl-4,1-benzothiazepin-2(1H)-one 4-oxides (1969) (6)
Synthesis and stereochemistry of perhydrobenzo[b]thiophene derivatives (1981) (6)
Metabolism of [3alpha-3H] 25-hydroxyvitamin D2 in kidneys isolated from normal and vitamin D2-intoxicated rats. (2000) (6)
C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1. (2004) (6)
Effect of 1α,25-dihydroxycholecalciferol analogs on bone resorption in vitro (1981) (6)
A total synthesis of racemic petaline (1966) (5)
Synthesis of Radioactive Dehydroepiandrosterone1,2 (1959) (5)
Metabolites and analogs of 1alpha,25-dihydroxyvitamin D(3): evaluation of actions in bone. (2001) (5)
Physiological significance of C-28 hydroxylation in the metabolism of 1alpha,25-dihydroxyvitamin D(2). (1999) (5)
Azasteroids. III1,2 (1962) (5)
1,25,28-trihydroxyvitamin D2 up-regulates renal vitamin D receptor without causing hypercalcemia (1993) (5)
D-Homosteroids. I. 3β-Hydroxy-17a,17a-dimethyl-D-homoandrostane-17-one and Related Compounds1 (1959) (5)
Dipolar Cycloaddition Route to the Synthesis of 1a,25-Dihydroxy-26-norvitamin D2 Derivatives (1993) (5)
CHAPTER 85 – Gemini: The 1,25-dihydroxy Vitamin D Analogs with Two Side-Chains (2005) (5)
3β-hydroxy-6α-methylpregn-4-en-20-one (1963) (4)
Metabolism of selective 20-epi-vitamin D3 analogs in rat osteosarcoma UMR-106 cells: Isolation and identification of four novel C-1 fatty acid esters of 1α,25-dihydroxy-16-ene-20-epi-vitamin D3 (2017) (4)
Isolation and identification of 1alpha-hydroxy-24-oxovitamin D3 and 1alpha,23-dihydroxy-24-oxovitamin D3: metabolites of 1alpha,24(R)-dihydroxyvitamin D3 produced in rat kidney. (1999) (4)
Growth-inhibition of human-melanoma cells by vitamin-d analogs. (1995) (4)
Metabolism and biological activity of 1,25(OH)2D2 and its metabolites in a chronic myelogenous leukemia cell line, rwleu-4 (1993) (4)
Chapter 5 The Cinchona Alkaloids (1973) (4)
Asymmetric Synthesis of a Key Ring A Synthon for 1α-Hydroxy-19-nor Vitamin D. (1998) (3)
D-Homosteroids. III. The Wagner-Meerwein Rearrangement of 20-Substituted Bisnorallocholanes1,2 (1960) (3)
Direct α‐Iodination of Cycloalkenones. (1992) (3)
The Stevens rearrangement of isoquinolinium salts. A novel synthesis of 1-benzyl-1,2,3,4-tetrahydroisoquinolines. (1969) (3)
The implementation of digital audio processors in analog multimedia audio systems (2003) (3)
Antimalarial activity of racemic 3-Epidihydroquinine, 3-Epidihydroquinidine and their various racemic analogs in mice infected withPlasmodium berghei (1973) (3)
Stereocontrolled Total Synthesis of 1α,25-Dihydroxyergocalciferol. (1986) (3)
SYNTHESIS AND STEREOCHEMISTRY OF PERHYDROBENZO(B)THIOPHENE DERIVATIVES (1982) (2)
Synthesis of D‐Biotin from L‐Cystine via Intramolecular [3 + 2] Cycloaddition (2010) (2)
VITAMIN D3 METABOLITES PART 1, SYNTHESIS OF 25-HYDROXYCHOLESTEROL (1974) (2)
Incorporation of tritium in unsaturated steroids: Pregnenolone-7α-H3 and progesterone-7α-H3 of very high specific activity (2004) (2)
Total synthesis of 1α,25,28-trihydroxyergocalciferol (1993) (2)
Production of antibodies to 1alpha,25-dihydroxycholecalciferol-25-hemisuccinate: development of a sensitive radioimmunoassay for 1alpha,25-dihydroxycholecalciferol [proceedings]. (1978) (2)
Calcitriol analogs cause differentiation of neoplastic cells in culture. (1995) (2)
A simple method for generation of antibodies with specificity for 1,25-dihydroxyergocalciferol and 1,25-dihydroxycholecalciferol (1983) (2)
1,25(OH)2D3 PROMOTES DIFFERENTIATION OF RESTING CHONDROCYTES TO HYPERTROPHIC CELLS IN VITRO: A MODEL SYSTEM FOR EVALUATING THE POTENCY OF VITAMIN D ANALOGS (1988) (2)
Effects of long-term administration of vitamin D 3 analogs to mice (2000) (2)
Abstract 644: A novel Gemini vitamin D analogue represses the expression of a stem cell marker CD44 in breast cancer (2010) (2)
A new antiandrogen. 6α-Bromo-17β-hydroxy-17α-methyl-4-oxa-5α-androstan-3-one (1970) (2)
Vitamin D3 derivatives (1993) (2)
Additions and Corrections - Stereoselective Total Synthesis of 1α,25-Dihydroxycholecalciferol (1982) (2)
A TOTAL SYNTHESIS OF BIOTIN BASED ON DERIVATIVES OF 2,5-DIHYDROTHIOPHENE (1977) (2)
1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway. (2000) (1)
New tissue-selective vit D receptor modulators (VDRMs) (2000) (1)
Abstract 1912: Reduction of microRNA-21 by vitamin D compounds during ductal carcinoma in situ transition to invasive ductal carcinoma (2015) (1)
CHIRALLY SELECTIVE SYNTHESIS OF NATURAL PRODUCTS. THE 10-HYDROXY ANALOGS OF DIHYDROQUININE (1981) (1)
D-Homosteroids. II. Derivatives of 3β-Hydroxy-17a,17a-dimethyl-D-homoandrostan-17-one1 (1960) (1)
Effect of 1 alpha, 25-dihydroxycholecalciferol analogs on bone resorption in vitro. (1981) (1)
Synthesis of 26,27-Hexadeutero and Epimeric 26-Trideutero 1,25-Dihvdroxycholecalciferols (2011) (1)
Total Synthesis of 1233A (I). (1994) (1)
Vitamin D3 metabolites. 3. Synthesis and X-ray analysis of 1 alpha,25-dihydroxycholesterol. (1974) (1)
VITAMIN D3 METABOLITES PART 2, FURTHER SYNTHESES OF 25-HYDROXYCHOLESTEROL (1974) (1)
REINVESTIGATION OF THE CLASSICAL SYNTHESIS OF CINCHONA ALKALOIDS PART 2, THE SYNTHESIS OF QUININE AND ITS NATURALLY OCCURRING DIASTEREOMERS FROM QUINOTOXINE (1973) (1)
Differential Effects on Leukemic Cell Growth, Differentiation, and Intestinal Calcium Absorption1 (1990) (1)
OLEFINIC NITRONE AND NITRILE OXIDE (3 + 2) CYCLOADDITIONS. A SHORT STEREOSPECIFIC SYNTHESIS OF BIOTIN FROM CYCLOHEPTENE (1980) (1)
THE STRUCTURE AND ABSOLUTE CONFIGURATION OF ARTEANNUIN B (1974) (1)
cis,trans-5,6,7,8-Diepoxy-8-carboxamido-5,6,7,8-tetrahydrotetrazolo[1,5-a]pyridine (1973) (1)
27-bishomo-Vitamin D 3 Analogs : A Unique Class of Potent Inhibitors of Proliferation of Prostate , Breast , and Hematopoietic Cancer Cells 1 (2006) (1)
Concise Synthesis of Dimethyl (2-Oxopropyl)phosphonate and Homologation of Aldehydes to Alkynes in a Tandem Process. (2009) (1)
Dipolar Cycloaddition Route to the Synthesis of 1α,25-Dihydroxy- 26-norvitamin D2 Derivatives. (2010) (0)
25-hydroxy vitamin D 3 derivatives, process for their preparation and medicament containing them (1989) (0)
Cells of Proliferation of Prostate , Breast , and Myeloid Leukemic : A New Class of Potent Inhibitors 3-16-ene-Vitamin D trans 5 , 6-Updated (1999) (0)
Cinchona alkaloids. Total synthesis of cinchonamine. (1976) (0)
The use of the optical position sensor for the protection of loudspeakers from cone over-excursion (2014) (0)
Abstract 2097: Gemini vitamin D analogs inhibit estrogen receptor positive and estrogen receptor negative mammary tumorigenesis without hypercalcemic toxicity (2008) (0)
metabolism to induce HL-60 cell differentiation without modulating calcium Development of a novel 1 , 25 ( OH ) 2-vitamin D 3 analog with potent ability (2003) (0)
Compounds derived from cholecalciferol, antitumor pharmaceutical composition and use thereof in the preparation of said pharmaceutical composition (1985) (0)
TOTALSYNTH. VON DIHYDROCINCHONAMIN (1972) (0)
16-dehydrovitamin d3 derivative (1989) (0)
Using a cholecalciferolderivates (1983) (0)
The fluorinated vitamin D3 derivative (1995) (0)
Convergent Synthesis of Vitamin D3 Metabolites. Control of the Stereoselectivity in Samarium-Induced Cyclopropanations of Cyclopentenes. (2010) (0)
Stereospecific Synthesis of the Lythgoe′s Ring A Aldehyde for the Preparation of 1α-Hydroxylated Tachysterols and Calciferols. (1987) (0)
STEREOCONTROLLED SYNTHESIS OF 25S,26-DIHYDROXY- AND 1α, 25S, 26-TRIHYDROXYCHOLECALCIFEROL SIDE CHAINS (1983) (0)
Beneficial effects of Vitamin D receptor agonists on retinal autoimmunity (131.30) (2007) (0)
Vitamin D3 analogues. (1997) (0)
Anitcancer Activity of Vitamin D Analogs (1999) (0)
Process for the preparation of derivatives of vitamin didehydro-d3. (Reservation of Art. 167.2 CPC). (1989) (0)
Using an analog of vitamins d3 for the treatment of autoimmune diabetes (2002) (0)
Chemical Conversion of Vitamin D3 to Calcitriol Lactone (2010) (0)
A process for the production of biotin and intermediates for this process (1978) (0)
Abstract 1248: The Gemini vitamin D analogue BXL0124 inhibits Notch signaling via HES1, resulting in the reduction of CD44+/CD24-/low subpopulation and proliferation of MCF10DCIS cells (2014) (0)
Vitamin-D Analogs : A New Class of Potent Inhibitors of Proliferation and Inducers of Differentiation of Human Myeloid Leukemia Cell Lines (1998) (0)
Asymmetric Synthesis of a Key 1α,25-Dihydroxy-Vitamin D3 Ring A Synthon. (1993) (0)
Process for the preparation of 1 alpha, 25-dihydroxycholecalciferol (1976) (0)
Cross-Linking of the Human Myeloid Cell Nuclear Differentiation Antigen to DNA in HL-60 Cells following 1 , 25-Dihydroxy Vitamin D 3-induced Monocyte Differentiation 1 (2006) (0)
Total Synthesis of 1α,25,28-Trihydroxyergocalciferol (I). (1994) (0)
Foerfarande Foer framstaellning of 4-amino-thiophene-3-karboxylsyraderivat with fysiologisk Effect (1977) (0)
Myeloid Differentiation Mediated Through New Potent Retinoids and Vitamin D3 Analogs (1996) (0)
NATURAL ABUNDANCE CARBON-13 NMR OF VITAMIN D3 METABOLITES (1980) (0)
Thiophene derivatives, their preparation and use (1978) (0)
Abstract 929: Repression of CD44 is a key molecular action of a novel Gemini vitamin D BXL0124 to inhibit breast cancer cell invasion induced by HGF/Met signaling (2012) (0)
The correction of low frequency non-linearities due to non-optimal Qtc in loudspeakers by the use of negative feedback (2014) (0)
New use of 1 alpha-fluoro-25-hydroxy-16-en-23-yn-cholecalciferol (1995) (0)
A process for the preparation of quinoline derivatives antipodes or racemates, or acid addition salts thereof. (1969) (0)
fluorinated analogues of vitamin d3. (1993) (0)
A process for preparing cholecalciferolderivater (1982) (0)
Remote Diastereoselection in the Asymmetric Synthesis of Pravastatin ( I). (1993) (0)
Reagent and method for determination of cholecalciferol (1978) (0)
1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells. (1996) (0)
A process for preparing hydroxycholesterinen (1974) (0)
A CHIRAL SYNTHESIS OF L-ACOSAMINE AND L-DAUNOSAMINE VIA AN ENANTIOSELECTIVE INTRAMOLECULAR(3 + 2)CYCLOADDITION (1981) (0)
A process for preparing methoxypsoralen (1977) (0)
THE STEREOSELECTIVITY OF KETONE REDUCTION WITH SPOROTRICHUM EXILE, RESOLUTION OF CIS- AND TRANS-2-BENZOYLOCTAHYDRO-6(2H)-ISOQUINOLONES (1974) (0)
SYNTHESIS OF D-BIOTIN FROM L-CYSTINE VIA INTRAMOLECULAR (3+2)CYCLOADDITION (1983) (0)
Isolation and identification of 1α-hydroxy-24-oxovitamin D 3 and 1α,23-dihydroxy-24-oxovitamin D 3 (1999) (0)
AN EFFICIENT STEREOSELECTIVE SYNTHESIS OF (.+-.)-SWEROSIDE AND (.+-.)-SECOLOGANIN AGLUCONE O-METHYL ETHERS (1978) (0)
Process for the preparation of therapeutically useful 23,24-didehydro-25-hydroksikalsiferolijohdannaisten (1989) (0)
A new antiandrogen, 6alpha-bromo-17 beta-hydroxy-17 alpha-methyl-4-oxa-5 alpha-androstan-3-one. (1970) (0)
A process for the preparation of benzothiazepine derivatives substituted basic or acid addition salts thereof. (1966) (0)
Cover Picture: Formal Desymmetrization of the Diastereotopic Chains in Gemini Calcitriol Derivatives with Two Different Side Chains at C‐20 (Eur. J. Org. Chem. 8/2004) (2004) (0)
Analogues de vitamine d3 de 1,3-dihydroxy-20,20-dialkyle (1998) (0)
Synthesis of D-Biotin from Cysteine. (1988) (0)
Remote Diastereoselection in the Asymmetric Total Synthesis of Mevinolin. (1989) (0)
Foerfarande Foer framstaellning of 26,26,26-trifluoro-1, 25-dihydroxikolekalciferol. (1985) (0)
differentiation, and induction of WAF1 in myeloid leukemia A new series of vitamin D analogs is highly active for clonal inhibition, (2011) (0)
REINVESTIGATION OF THE CLASSICAL SYNTHESIS OF CINCHONA ALKALOIDS PART 1, A NEW SYNTHESIS OF HOMOMEXOQUINENE AND QUINOTOXINE (1973) (0)
Pharmaceutical composition for treating skin disease (1989) (0)
American Society of Colon and Rectal Surgeons 95th Annual Convention Podium and Poster Abstracts June 9–14, 1996 Seattle, Washington (1996) (0)
TOTAL SYNTHESIS OF ACOSAMINE AND DAUNOSAMINE UTILIZING A DIASTEREOSELECTIVE INTRAMOLECULAR (3 + 2) CYCLOADDITION (1985) (0)
Vitamin D 3 analog (1993) (0)
1,25(OH)2VITAMIN D3 ANALOGS: COMPARISON OF 1,25(OH)2D3 RECEPTOR LIGAND SPECIFICITY AND BIOLOGICAL ACTIVITY IN THE CHICK AND HUMAN PROMYELOCYTE (HL-60) CELLS. (1988) (0)
The Cinchona Group (2008) (0)
Control of Stereoselectivity in Samarium Metal-Induced Cyclopropanations. Synthesis of 1,25-Dihydroxycholecalciferol. (2010) (0)
A process for the preparation of therapeutically useful 25-hydroxy vitamin D derivatives (1989) (0)
A STEREOSPECIFIC SYNTHESIS OF BIOTIN VIA THIOPHENE INTERMEDIATES (1977) (0)
Abstract 1236: A gemini vitamin D analogue, BXL0124, represses mammosphere formation and decreases expression of stem cell markers in MCF10DCIS breast cancer cells (2014) (0)
STEREOSELECTIVE INTRODUCTION OF STEROID SIDE CHAINS AT C(17) AND C(20) (1981) (0)
(25 S)-1α,25,26-TRIHYDROXYCHOLECALCIFEROL, A NEW VITAMIN D3 METABOLITE: SYNTHESIS AND ABSOLUTE STEREOCHEMISTRY AT C(25). PRELIMINARY COMMUNICATION (1982) (0)
Correction. The Structures of Two Diastereoisomeric Sulfoxides. 3,5-Dihydro-3-methyl-4,1-benzothiazepin-2(1H)-one 4-Oxides. (1970) (0)
Novel Deuterated Gemini-Vitamin D3 Analogs Have Potent Antitumor Activity. (2007) (0)
Asymmetric Hydroboration of 5‐Substituted Cyclopentadienes: Synthesis of Methyl (1R,5R)‐5‐Hydroxy‐2‐Cyclopentene‐1‐Acetate (2003) (0)
Contents Vol. 75, 2008 (2008) (0)
Vitamin D Receptor Agonists Can Prevent and Treat Experimental Autoimmune Uveoretinitis (2006) (0)
Subject Index Vol. 75, 2008 (2008) (0)
EIN NEUES ANTIANDROGEN, 6ALPHA-BROM-17BETA-HYDROXY-17ALPHA-METHYL-4-OXA-5ALPHA-ANDROSTAN-3-ON (V) (1970) (0)
A process for preparing 25hydroxycholesterin (1974) (0)
A New Approach to the Total Synthesis of Pseudomonic Acid C. (1987) (0)
Metabolism of 1alpha,25-dihydroxyvitamin D(3) in human promyelocytic leukemia (HL-60) cells: in vitro biological activities of the natural metabolites of 1alpha,25-dihydroxyvitamin D(3) produced in HL-60 cells. (2001) (0)
Correction. Syntheses in the Isoquinoline Series. Synthesis and Chemical Transformation of the 2,3-Dihydro-4(1H)-isoquinolones (1968) (0)
Hematopoietic Cancer Cells Potent Inhibitors of Proliferation of Prostate , Breast , and Analogs : A Unique Class of 319-nor-26 , 27-bishomo-Vitamin D Updated (2006) (0)
VITAMIN D3 METABOLITES PART 3, SYNTHESIS AN X-RAY ANALYSIS OF 1ALPHA,25-DIHYDROXYCHOLESTEROL (1974) (0)
1,25-dihydroxyvitamin 16,22,23-trisdehydro-cholecalciferolderivativer (1997) (0)
Effects of analogs of 1,25(OH)2 Vitamin D3 on the proliferation and differentiation of the human chronic myelogenous leukemia cell line, RWLeu-4 (2005) (0)
Abstract 180: Inhibition of tumorigenesis by a novel Gemini vitamin D analog BXL0124 and a synthetic triterpenoid CDDO-Im in MMTV-HER2/neu transgenic mice. (2013) (0)
TOTAL SYNTHESIS OF RACEMIC AJMALICINE AND 19-EPI-AJMALICINE (1981) (0)
AN EVALUATION OF ANALOGS OF 1,25-DIHYDROXYVITAMIN D3 ON THE INHIBITION OF PROLIFERATION AND INDUCTION OF TERMINAL DIFFERENTIATION IN CULTURED HUMAN NORMAL KERATINOCYTES. (1988) (0)
Abstract 184: A gemini vVitamin D analog, BXL0124, inhibits mammary tumorigenesis by delaying the transition of ductal carcinoma in situ to iInvasive breast carcinoma. (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Milan Radoje Uskokovic?

Milan Radoje Uskokovic is affiliated with the following schools: